Treatment of Libman-Sacks endocarditis by combination of warfarin and immunosuppressive therapy
Antiphospholipid syndrome (APS) is a clinical disorder that creates an increased risk of arterial or venous thrombotic events or pregnancy-associated complications and includes the presence of autoantibodies against negatively charged phospholipids. This syndrome is often associated with systemic au...
Saved in:
Published in: | Türk Kardiyoloji Derneği arşivi Vol. 47; no. 8; pp. 687 - 690 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
KARE Publishing
01-12-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Antiphospholipid syndrome (APS) is a clinical disorder that creates an increased risk of arterial or venous thrombotic events or pregnancy-associated complications and includes the presence of autoantibodies against negatively charged phospholipids. This syndrome is often associated with systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). Libman-Sacks endocarditis is a form of non-bacterial thrombotic endocarditis and is infrequently seen in APS. There are few data documenting the echocardiographic response of APS valve disease to medical treatment. This is an unusual case of a young female patient with SLE and APS who had chorea and non-bacterial thrombotic aortic valve endocarditis. Echocardiography revealed that the vegetation had receded after a combination of warfarin and immunosuppressive therapy. |
---|---|
ISSN: | 1016-5169 |
DOI: | 10.5543/tkda.2019.29213 |